These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24116718)

  • 1. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs.
    Corzo JL; Zambonino MA; Muñoz C; Mayorga C; Requena G; Urda A; Gallego C; Blanca M; Torres MJ
    Br J Dermatol; 2014 Mar; 170(3):725-9. PubMed ID: 24116718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
    Doña I; Blanca-López N; Jagemann LR; Torres MJ; Rondón C; Campo P; Gómez AI; Fernández J; Laguna JJ; Rosado A; Blanca M; Canto G
    Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema.
    Göksel O; Aydin O; Misirligil Z; Demirel YS; Bavbek S
    J Dermatol; 2010 Nov; 37(11):973-9. PubMed ID: 21039786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs.
    Muratore L; Ventura M; Calogiuri G; Calcagnile F; Quarta E; Muratore M; Ferrannini A
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):168-71. PubMed ID: 17304885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib.
    Bavbek S; Celik G; Ozer F; Mungan D; Misirligil Z
    J Asthma; 2004 Feb; 41(1):67-75. PubMed ID: 15046380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide.
    Inomata N; Osuna H; Yamaguchi J; Onoda M; Takeshita Y; Chiba Y; Kambara T; Ikezawa Z
    J Dermatol; 2007 Mar; 34(3):172-7. PubMed ID: 17291297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity?
    Çelik GE; Erkekol FÖ; Aydın Ö; Demirel YS; Mısırlıgil Z
    Allergol Immunopathol (Madr); 2013; 41(3):181-8. PubMed ID: 23031659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meloxicam tolerance in hypersensitivity to nonsteroidal anti-inflammatory drugs.
    Domingo MV; Marchuet MJ; Culla MT; Joanpere RS; Guadaño EM
    J Investig Allergol Clin Immunol; 2006; 16(6):364-6. PubMed ID: 17153884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meloxicam and/or Etoricoxib Could Be Administered Safely in Two Equal Doses during an Open Oral Challenge in Patients with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity.
    Rojas-Mejía DV; Silva Espinosa DL; Martínez DM; Ramírez Zuluaga LF; Serrano Reyes CD
    Int Arch Allergy Immunol; 2021; 182(5):433-439. PubMed ID: 33592604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study.
    Meek IL; Vonkeman HE; Kasemier J; Movig KL; van de Laar MA
    Eur J Clin Pharmacol; 2013 Mar; 69(3):365-71. PubMed ID: 22890587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal exfoliation as a selective reaction to etoricoxib.
    Patanè M; Isola S; Gangemi S; Minciullo PL
    J Clin Pharm Ther; 2016 Dec; 41(6):722-724. PubMed ID: 27576781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study.
    Bavbek S; Dursun AB; Dursun E; Eryilmaz A; Misirligil Z
    Int Arch Allergy Immunol; 2007; 142(1):64-9. PubMed ID: 17016059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):34-8. PubMed ID: 15702813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs.
    Senna GE; Passalacqua G; Dama A; Crivellaro M; Schiappoli M; Bonadonna P; Canonica GW
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):393-6. PubMed ID: 14768525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative Drug Safety in Children with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity.
    Aytekin Güvenir F; Turgay Yağmur İ; Dibek Mısırlıoğlu E
    Int Arch Allergy Immunol; 2024; 185(10):921-927. PubMed ID: 38815557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
    El Miedany Y; Youssef S; Ahmed I; El Gaafary M
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema.
    Doña I; Barrionuevo E; Salas M; Cornejo-García JA; Perkins JR; Bogas G; Prieto A; Torres MJ
    Allergy; 2017 Sep; 72(9):1346-1355. PubMed ID: 28226401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term tolerability of etoricoxib in different types of NSAID-intolerant subjects.
    Pagani M; Bonadonna P; Dama A; Senna GE; Vescovi PP; Antico A
    Eur Ann Allergy Clin Immunol; 2010 Dec; 42(6):216-20. PubMed ID: 21287945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.